Table 1.

Patient characteristics and ORs with 95% CIs of selection to AHCT within 18 mo of diagnosis among stage IB+ MCL patients up to 65 y of age diagnosed in Sweden between January 2000 and June 2014

VariablenAHCT ≤ 18 moNo AHCT ≤ 18 moUnadjusted OR (95% CI)
Overall (row %) 369 (100) 221 (59.9) 148 (40.1)  
Marital status at diagnosis (col %)     
 Married 216 (58.5) 141 (63.8) 75 (50.7) 1.00 
 Never married 68 (18.4) 39 (17.7) 29 (19.6) 0.72 (0.41-1.25) 
 Divorced 73 (19.8) 37 (16.7) 36 (24.3) 0.55 (0.32-0.94) 
 Widow(er) 12 (3.3) 4 (1.8) 8 (5.4) 0.27 (0.08-0.91) 
Highest achieved education level (col %)     
 Up to 9 y of schooling 80 (21.7) 35 (15.8) 45 (30.4) 0.44 (0.26-0.75) 
 10 to 12 y of schooling 175 (47.4) 112 (50.7) 63 (42.6) 1.00 
 >12 y of schooling 103 (27.9) 68 (30.8) 35 (23.7) 1.09 (0.66-1.82) 
 Missing 11 (3.0) 6 (2.7) 5 (3.4) · 
Country of birth (col %)     
 Sweden 321 (87.0) 189 (85.5) 132 (89.2) 1.00 
 Foreign 48 (13.0) 32 (14.5) 16 (10.8) 1.40 (0.74-2.65) 
Sex (col %)     
 Male 288 (78.1) 171 (77.4) 117 (79.1) 1.00 
 Female 81 (21.9) 50 (22.6) 31 (20.9) 1.10 (0.67-1.83) 
CCI (col %)     
 0 277 (75.1) 182 (82.4) 95 (64.2) 1.00 
 1 45 (12.2) 23 (10.4) 22 (14.9) 0.55 (0.29-1.03) 
 2+ 47 (12.7) 16 (7.2) 31 (21.0) 0.27 (0.14-0.52) 
Year of diagnosis (col %)     
 2000 to 2004 114 (30.9) 65 (29.4) 49 (33.1) 1.00 
 2005 to 2009 120 (32.5) 75 (33.9) 45 (30.4) 1.26 (0.74-2.12) 
 2010 to 2014 135 (36.6) 81 (36.7) 54 (36.5) 1.13 (0.68-1.88) 
Age at diagnosis, y (col %)     
 <50 51 (13.8) 39 (17.7) 12 (8.1) 1.00 
 50 to 59 148 (40.1) 104 (47.1) 44 (29.7) 0.73 (0.35-1.52) 
 60 to 65 170 (46.1) 78 (35.3) 92 (62.2) 0.26 (0.13-0.53) 
Hospital type where initial diagnosis was made (col %)     
 University 184 (53.4) 118 (53.4) 66 (44.6) 1.00 
 Regional 127 (34.4) 67 (30.3) 60 (40.5) 0.62 (0.39-0.99) 
 Local 58 (15.7) 36 (16.3) 22 (14.9) 0.92 (0.50-1.68) 
Stage (col %)     
 Ann Arbor IB and II 37 (10.0) 19 (8.6) 18 (12.2) 1.00 
 Ann Arbor III 49 (13.3) 33 (14.9) 16 (10.8) 1.95 (0.81-4.70) 
 Ann Arbor IV 279 (75.6) 168 (76.0) 111 (75.0) 1.43 (0.72-2.85) 
 Missing 4 (1.1) 1 (0.5) 3 (2.0)  
MCL-specific international prognostic index (col %)     
 Low risk (<5.7) 114 (30.9) 73 (33.0) 41 (27.7) 1.00 
 Intermediate risk (5.7-6.1) 92 (24.9) 55 (24.9) 37 (25.0) 0.83 (0.47-1.47) 
 High risk (>6.1) 71 (19.2) 38 (17.2) 33 (22.3) 0.65 (0.35-1.18) 
 Missing 92 (24.9) 55 (24.9) 37 (25.0)  
Performance status (col %)     
 ECOG 0 to 1 332 (90.0) 207 (93.7) 125 (84.5) 1.00 
 ECOG 2 to 4 31 (8.4) 12 (5.4) 19 (12.8) 0.38 (0.18-0.81) 
 Missing 6 (1.6) 2 (0.9) 4 (2.7)  
VariablenAHCT ≤ 18 moNo AHCT ≤ 18 moUnadjusted OR (95% CI)
Overall (row %) 369 (100) 221 (59.9) 148 (40.1)  
Marital status at diagnosis (col %)     
 Married 216 (58.5) 141 (63.8) 75 (50.7) 1.00 
 Never married 68 (18.4) 39 (17.7) 29 (19.6) 0.72 (0.41-1.25) 
 Divorced 73 (19.8) 37 (16.7) 36 (24.3) 0.55 (0.32-0.94) 
 Widow(er) 12 (3.3) 4 (1.8) 8 (5.4) 0.27 (0.08-0.91) 
Highest achieved education level (col %)     
 Up to 9 y of schooling 80 (21.7) 35 (15.8) 45 (30.4) 0.44 (0.26-0.75) 
 10 to 12 y of schooling 175 (47.4) 112 (50.7) 63 (42.6) 1.00 
 >12 y of schooling 103 (27.9) 68 (30.8) 35 (23.7) 1.09 (0.66-1.82) 
 Missing 11 (3.0) 6 (2.7) 5 (3.4) · 
Country of birth (col %)     
 Sweden 321 (87.0) 189 (85.5) 132 (89.2) 1.00 
 Foreign 48 (13.0) 32 (14.5) 16 (10.8) 1.40 (0.74-2.65) 
Sex (col %)     
 Male 288 (78.1) 171 (77.4) 117 (79.1) 1.00 
 Female 81 (21.9) 50 (22.6) 31 (20.9) 1.10 (0.67-1.83) 
CCI (col %)     
 0 277 (75.1) 182 (82.4) 95 (64.2) 1.00 
 1 45 (12.2) 23 (10.4) 22 (14.9) 0.55 (0.29-1.03) 
 2+ 47 (12.7) 16 (7.2) 31 (21.0) 0.27 (0.14-0.52) 
Year of diagnosis (col %)     
 2000 to 2004 114 (30.9) 65 (29.4) 49 (33.1) 1.00 
 2005 to 2009 120 (32.5) 75 (33.9) 45 (30.4) 1.26 (0.74-2.12) 
 2010 to 2014 135 (36.6) 81 (36.7) 54 (36.5) 1.13 (0.68-1.88) 
Age at diagnosis, y (col %)     
 <50 51 (13.8) 39 (17.7) 12 (8.1) 1.00 
 50 to 59 148 (40.1) 104 (47.1) 44 (29.7) 0.73 (0.35-1.52) 
 60 to 65 170 (46.1) 78 (35.3) 92 (62.2) 0.26 (0.13-0.53) 
Hospital type where initial diagnosis was made (col %)     
 University 184 (53.4) 118 (53.4) 66 (44.6) 1.00 
 Regional 127 (34.4) 67 (30.3) 60 (40.5) 0.62 (0.39-0.99) 
 Local 58 (15.7) 36 (16.3) 22 (14.9) 0.92 (0.50-1.68) 
Stage (col %)     
 Ann Arbor IB and II 37 (10.0) 19 (8.6) 18 (12.2) 1.00 
 Ann Arbor III 49 (13.3) 33 (14.9) 16 (10.8) 1.95 (0.81-4.70) 
 Ann Arbor IV 279 (75.6) 168 (76.0) 111 (75.0) 1.43 (0.72-2.85) 
 Missing 4 (1.1) 1 (0.5) 3 (2.0)  
MCL-specific international prognostic index (col %)     
 Low risk (<5.7) 114 (30.9) 73 (33.0) 41 (27.7) 1.00 
 Intermediate risk (5.7-6.1) 92 (24.9) 55 (24.9) 37 (25.0) 0.83 (0.47-1.47) 
 High risk (>6.1) 71 (19.2) 38 (17.2) 33 (22.3) 0.65 (0.35-1.18) 
 Missing 92 (24.9) 55 (24.9) 37 (25.0)  
Performance status (col %)     
 ECOG 0 to 1 332 (90.0) 207 (93.7) 125 (84.5) 1.00 
 ECOG 2 to 4 31 (8.4) 12 (5.4) 19 (12.8) 0.38 (0.18-0.81) 
 Missing 6 (1.6) 2 (0.9) 4 (2.7)  

Due to rounding, not all percentages add up to 100. Bold indicates significant exposures associated with a lower chance of being treated with AHCT.

col, column.

or Create an Account

Close Modal
Close Modal